Antineoplaston Therapy in Treating Children With Brain Tumors

Completed · Phase 2

Conditions studied: Childhood Brain Tumors

In brief

RATIONALE: Current therapies for childhood brain tumors provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of childhood brain tumors. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on children (\> 6 months of age) with brain tumors.

Key facts

Study ID

NCT00003458

Run by

Burzynski Research Institute

People needed

34

Starts

1996-09-01

Expected to finish

2014-09-01

Last updated by the study team

2022-03-07

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.